Dietary Intake of Salmon and Bone Health
Intake of Dietary Vitamin D and K From Tailor-made Atlantic Salmon and Bone Health - A Randomized Intervention Study
1 other identifier
interventional
122
1 country
1
Brief Summary
The aims of this study were to investigate how intake of tailor-made salmon affected bone biomarkers, nutritional status, as well as body composition and bone mineral density. The 122 healthy postmenopausal women included in this 12 weeks intervention study were randomized into four groups: three salmon groups (with three different vitamin D3/vitamin K1 combinations) and one tablet group (vitamin D and Calcium).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 18, 2015
CompletedFirst Posted
Study publicly available on registry
November 26, 2015
CompletedNovember 26, 2015
November 1, 2015
5 months
November 18, 2015
November 24, 2015
Conditions
Outcome Measures
Primary Outcomes (7)
Bone-specific alkaline phosphatase
Serum (µg/l)
3 months
Osteocalcin
Serum (ng/ml)
3 months
Undercarboxylated osteocalcin (GLU)
Serum (ng/ml)
3 months
Carboxylated osteocalcine (GLA)
Serum (ng/ml)
3 months
GLU/GLA-ratio
Ratio of undercarboxylated osteocalcin and carboxylated osteocalcine
3 months
N-telopeptides/creatinine
Urinary (mmol/l)
3 months
Deoxypyridinoline/creatinine
Urinary (mmol/l)
3 months
Secondary Outcomes (6)
25-hyroxyvitamin D
3 months
Eicosapentaenoic acids
3 months
Docosahexaenoic acids
3 months
Omega-3 index
3 months
Body composition
3 months
- +1 more secondary outcomes
Study Arms (4)
Salmon (HD+HK)
EXPERIMENTALTailor-made salmon with high levels of vitamin D3 and K1
Salmon (LD+HK)
EXPERIMENTALTailor-made salmon with low levels of vitamin D3 and high K1
Salmon (HD+LK)
EXPERIMENTALTailor-made salmon with high levels of vitamin D3 and low K1
Supplement (vitamin D + Calcium)
EXPERIMENTALSupplement with vitamin D and Calcium
Interventions
The aims were to investigate how intake of tailor-made salmon with high levels of vitamin D3 and K1 affected bone biomarkers, nutritional status (vitamin D, omega-3), as well as body composition and bone mineral density.
The aims were to investigate how intake of tailor-made salmon with low levels of vitamin D3 and high K1 affected bone biomarkers, nutritional status (vitamin D, omega-3), as well as body composition and bone mineral density.
The aims were to investigate how intake of tailor-made salmon with high levels of vitamin D3 and low K1 affected bone biomarkers, nutritional status (vitamin D, omega-3), as well as body composition and bone mineral density.
The aims were to investigate how supplement with vitamin D and Calcium affected bone biomarkers, nutritional status (vitamin D, omega-3), as well as body composition and bone mineral density.
Eligibility Criteria
You may qualify if:
- Postmenopausal women
- Caucasian ethnicity
- Age range 50-65 years
- Having postmenopausal age of at least one year
You may not qualify if:
- Osteoporotic fractures
- Medical treatment for osteoporosis
- Warfarin treatment
- Creatinine above or below normal range
- Hypervitaminosis D
- Malabsorption syndrome
- Inflammatory bowel disease
- Inflammatory rheumatic diseases
- Women who had planned to go away on holiday during the intervention could not participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NIFES
Bergen, 5817, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ingvild E Graff, PhD
NIFES, postboks 2029 Nordnes, 5815 Bergen, Norway
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Jannike Øyen, PhD
Study Record Dates
First Submitted
November 18, 2015
First Posted
November 26, 2015
Study Start
January 1, 2009
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
November 26, 2015
Record last verified: 2015-11